Stellenangebot: Postdoc - Genetic Toxicology/ecNGS bei Boehringer Ingelheim Pharma GmbH & Co. KG
Das Wichtigste im Überblick
Besondere Merkmale
Arbeitsort
Biberach an der RißAngebotsart
ArbeitAnstellungsart
VollzeitBeginn
ab sofortBerufsbezeichnung
- Biowissenschaftler/in
Stellenbeschreibung
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,500 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more at www.boehringer-ingelheim.com
The Position
Are you ready to take the next step in your scientific career and contribute to cutting-edge research in genetic toxicology? At our research site in Biberach an der Riss, Boehringer Ingelheim offers a two-year Postdoctoral Researcher position within the Global Non-Clinical Safety Science Department.
We are looking for a highly motivated scientist to join our Genetic Toxicology team and lead the implementation of the innovative error-corrected next-generation sequencing (ecNGS) technology.
In this role, you will independently drive experimental research, analyze and interpret complex data, and contribute to digital innovation. Your work will lay the foundation for future applications of ecNGS in the safety assessment of drug candidates, making a tangible impact on the development of life-saving therapies.
If you are passionate about combining experimental research with cutting-edge technology and data analysis, we invite you to become part of our dynamic team and shape the future of drug safety science!
Discover our Biberach site: xplorebiberach.com
This Position is limited for 2 years.
Note: To make it easier to find our job advertisements, we use the usual designation "postdoc". Of course, this advertisement is not only addressed to applicants directly after completing their doctorate, but to all qualified candidates.
Tasks & responsibilities
- In your new role, you will establish and validate the innovative error-corrected next-generation sequencing (ecNGS) technology for application in genetic toxicology.
- You will optionally build an internal platform for the analysis, interpretation, and visualization of sequencing data.
- Moreover, you will work in a regulated environment and ensure scientifically sound, high-quality, and traceable documentation of all activities and results.
- You will lead the scientific implementation of ecNGS within the organization and take overall responsibility for the successful execution of the project.
- As a Postdoc, you will present scientific findings to internal stakeholders. Additionally, you will share your research at external scientific conferences, workshops, and expert meetings and actively engage in scientific networking to establish and strengthen external collaborations.
Requirements
- PhD in Biology, Molecular Biology, Genetics, Bioinformatics, or a related life sciences discipline with a strong understanding of genetic toxicology, ideally with interdisciplinary expertise at the interface of biology and bioinformatics/data science
- Hands-on experience with next-generation sequencing (NGS) technologies and NGS-based genomic variant analysis, including variant identification, annotation, and biological interpretation
- Optionally proficiency in programming with R/Bioconductor and/or Python, along with a basic understanding of command line coding, code repositories, and high-performance computing systems and/or cloud systems would be an advantage
- Ability to work independently, in a structured manner, and with a high level of scientific rigor and attention to detail
- Effective communication skills across interdisciplinary teams, with the ability to present scientific results clearly to diverse audiences
- Enthusiasm for developing and implementing innovative methodologies and thriving in an international and interdisciplinary research environment
As part of our commitment to transparency and fairness, salary information will be shared during the recruitment process. We also offer a comprehensive benefits and wellbeing package.
Applications from persons with severe disabilities are warmly welcomed. In cases of equal qualifications, such applicants will be given preferential consideration in the selection process.
With us, you can develop your own path in a company with a culture that knows our differences are our strengths - and break new ground in the drive to make millions of lives better.
Here, your development is our priority. Supporting you to build a career as part of a workplace that is independent, authentic and bold, while tackling challenging work in a respectful and friendly environment where everyone is valued and welcomed.
Alongside, you have access to programs and groups that ensure your health and wellbeing are looked after - as we make major investments to drive global accessibility to healthcare. By being part of a team that is constantly innovating, you'll be helping to transform lives for generations.
Want to learn more? Visit https://www.boehringer-ingelheim.com
If you have any questions about the job posting or process - please contact our HR Direct Team, Tel: +49 (0) 6132 77-3330 or via mail: hr.de@boehringer-ingelheim.com
Recruitment process:
Step 1: Online application - The job posting is presumably online until October 30th, 2026.
Step 2: Virtual meeting beginning of November
Step 3: On-site interviews mid of November
Please include the following documents when applying for this position: motivation letter & current certificates, references
Arbeitsorte
Unternehmensdarstellung: Boehringer Ingelheim Pharma GmbH & Co. KG
In diesem Dokument befinden sich aus Sicherheitsgründen keine Kontaktdaten des Arbeitgebers. Wenn Sie diese sehen möchten, lösen Sie bitte die Sicherheitsfrage und laden Sie das PDF erneut.